CClinicalTrials.gg
CompletedNCT06731686Updated Dec 12, 2024

Single-center Retrospective Study : Developmental Trajectories of Children Born Prematurely Before 32 Weeks Assessed With the Revised Brunet Lézine Scale at 1, 2 and 3 Years

An observational study in Premature Birth, sponsored by Centre Hospitalier Intercommunal Creteil. Completed at 1 site in France. Open to participants aged 2 Months to 32 Months. Per ClinicalTrials.gov, last updated 2024-12-12.

Sponsored by Centre Hospitalier Intercommunal Creteil · Observational

Study type
Observational
Model
Cohort
Time perspective
Retrospective
Enrollment
1,000
Ages
2 Months to 32 Months
Sex
All
01

Study summary

This study will assess professionals in the CHI Créteil neonatal department and the Val de Marne perinatal network to gain a better understanding of the developmental trajectories of children hospitalized at the CHI Créteil, with a view to optimizing their care in the long term

02

Conditions studied

  • Premature Birth

Browse trials for

Keywords

  • Developmental trajectories
  • Revised Brunet Lézine
  • movement and posture
  • language
  • socialization
  • coordination
03

In context

Premature Birth

2,554 studies on the registry are indexed under Premature Birth; 498 are open to participants now.

This study's enrollment of 1,000 is above the median of 112 across 777 observational studies indexed under Premature Birth.

Browse Premature Birth studies →

Lead sponsor

Centre Hospitalier Intercommunal Creteil is the lead sponsor of 131 studies on the registry; 36 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Months to 32 Months
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Children born prematurely before 32 weeks

Inclusion criteria

  • Children born at CHI Créteil between 2012 and 2022, included in the Val de Marne perinatal network.
  • Children seen in pediatrician-psychomotor consultation with assessment by the BLR scale at 1 year AC.

Exclusion criteria

Exclusion Criteria:

  • Children born with a term of birth ≥ 32 weeks + 1 day.
  • Child removed from the Val de Marne perinatal network monitoring from the age of 1 year AC: Death or parental decision.
  • Children presenting with cerebral palsy, blindness or deafness at the age of 1 year AC.
05

Study design

Observational model
Cohort
Time perspective
Retrospective
Enrollment
1,000 participants (actual)
Patient registry
No

Interventions

  • OtherRetrospective study

    Collection of children's datas

06

What researchers measure

Primary outcomes

  1. Overall DQ obtained on the BLR scale at 1, 2 and 3 years, collected by the psychomotor therapists at CHI Créteil.

    Time frame: 1, 2 and 3 years

Secondary outcomes

  1. Analysis of the 4 sub-scores (movement and posture, language, socialization, coordination) obtained on the BLR scale at 1, 2 and 3 years, collected by the psychomotor therapists at CHI Créteil.

    Time frame: 1,2 and 3 years

  2. Analysis of family socio-demographic data : level of education

    Time frame: 1,2 and 3 years

  3. Analysis of family socio-demographic data : age of parents

    Time frame: 1,2 and 3 years

  4. Analysis of birth data : term

    Time frame: 1, 2 and 3 years

  5. Analysis of birth data : weight

    Time frame: 1,2 and 3 years

  6. Analysis of duration of hospitalization

    Time frame: 1,2 and 3 years

  7. Evaluate the concordance of BLR scale at 5 years with the measurement scores (not validated) used by the Val de Marne perinatal network (and all the Ile de France perinatal networks) filed out during the same consultations

    Time frame: 5 years

  8. Evaluate the concordance of BLR scale at 5 years with the measurement scores (not validated) used by the Val de Marne perinatal network (and all the Ile de France perinatal networks) filed out during the same consultations

    Time frame: 1,2 and 3 years

07

Study locations

1 site
  • CHI Créteil
    Créteil, 94000, France
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Dec 12, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06731686
Lead sponsor
Centre Hospitalier Intercommunal Creteil
Responsible party
Sponsor
First posted
Dec 12, 2024
Start date
Nov 23, 2023
Primary completion
Jun 17, 2024
Completion
Jun 17, 2024
Last update
Dec 12, 2024

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion